Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|April 25, 2001
Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemiaR Morariu-Zamfir, V Rocha, A Devergie, et al.
Blood|October 6, 2001
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patientsM Leporrier, S Chevret, B Cazin, et al.
Bone Marrow Transplantation|December 24, 2008
Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit?E Merlin, S Zohar, C Jérôme, et al.
Journal of Viral Hepatitis|December 22, 1999
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 groupT Poynard, V Daurat, S Chevret, et al.
Leukemia|October 20, 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa groupA-L Taksin, O Legrand, E Raffoux, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled TrialA Senéjoux, L Siproudhis, L Abramowitz, et al.
Gynecologie, Obstetrique & Fertilite|March 14, 2007
[Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]P Rozenberg, L Bussières, S Chevret, et al.
Intensive Care Medicine|January 13, 2015
Prognosis of neutropenic patients admitted to the intensive care unitD Mokart, M Darmon, M Resche-Rigon, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Pageof 22